Axcella Health Inc (AXLA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
William R. Hinshaw
Employees:
60
840 MEMORIAL DRIVE, THIRD FLOOR, CAMBRIDGE, MA 02139
617-868-0949

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction of risk of overt hepatic encephalopathy recurrence.

Data derived from most recent annual or quarterly report
Market Cap 118.821 Million Shares Outstanding52.576 Million Avg 30-day Volume 88.826 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.47
Price to Revenue0.0 Debt to Equity1.1391 EBITDA-61.562 Million
Price to Book Value3.6192 Operating Margin0.0 Enterprise Value103.123 Million
Current Ratio5.581 EPS Growth0.045 Quick Ratio0.157
1 Yr BETA 1.1647 52-week High/Low 4.4 / 1.35 Profit Margin0.0
Operating Cash Flow Growth-8.9409 Altman Z-Score-9.41 Free Cash Flow to Firm 10.139 Million
View SEC Filings from AXLA instead.

View recent insider trading info

Funds Holding AXLA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AXLA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-02:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-26:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-18:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-03-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-10:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KOZIEL MARGARET CHIEF MEDICAL OFFICER

    • Officer
    26,109 2022-06-01 5

    SEKHRI PAUL J

    • Director
    40,000 2022-05-19 2

    EPSTEIN DAVID R

    • Director
    209,756 2022-05-19 10

    ROSENBLATT MICHAEL

    • Director
    40,000 2022-05-19 2

    BAIRD WILLIAM D III

    • Director
    20,000 2022-05-19 1

    SOHN CATHERINE A.

    • Director
    20,000 2022-05-19 1

    PISANO GARY P.

    • Director
    20,000 2022-05-19 2

    RONDINONE CRISTINA

    • Director
    20,000 2022-05-19 1

    HENDRIX MARTIN

    • Director
    40,000 2022-05-19 2

    SOCIETE DES PRODUITS NESTLE S.A.

    NESTLE SA

    • 10% Owner
    7,446,902 2022-03-16 1

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    18,867,785 2022-03-16 1

    CRANE ROBERT CHIEF FINANCIAL OFFICER

    • Officer
    125,000 2022-03-16 3

    HINSHAW WILLIAM PRESIDENT & CEO

    • Officer
    • Director
    48,012 2022-03-16 3

    FEHLNER PAUL SVP & CHIEF LEGAL OFFICER

    • Officer
    20,802 2022-03-16 2

    SCHECTER ALISON D. PRESIDENT - RESEARCH & DEV.

    • Officer
    56,000 2022-02-08 2

    DEAN VIRGINIA R SVP, CHIEF PEOPLE OFFICER

    • Officer
    71,400 2022-02-08 1

    BEHAR GREGORY

    • Director
    20,000 2021-05-20 0

    HOGE STEPHEN

    • Director
    20,000 2021-05-20 0

    ARADHYE SHREERAM

    • Director
    20,000 2021-05-20 0

    CHARDONNET LAURENT CHIEF FINANCIAL OFFICER

    • Officer
    6,266 2021-02-09 0

    CHAKRAVARTHY MANU SVP & CHIEF MEDICAL OFFICER

    • Officer
    0 2021-02-09 0

    BERRY DAVID A

    • Director
    No longer subject to file 2020-05-20 0

    NESTLE HEALTH SCIENCE US HOLDINGS, INC.

    SOCIETE DES PRODUITS NESTLE S.A.

    NESTLE SA

    NIMCO US, INC.

    NESTLE US HOLDCO, INC.

    • 10% Owner
    4,305,541 2020-05-18 0

    TRAMONTIN TONY SVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2019-12-18 0

    MITCHENER STEPHEN SVP & CHIEF BUSINESS OFFICER

    • Officer
    0 2019-12-18 0

    KING-JONES HEIDY GENERAL COUNSEL, SVP LEGAL

    • Officer
    0 2019-12-18 0

    MALTBIE SHANE SEE REMARKS

    • Officer
    4,071 2019-08-21 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURELABS IV, LLC

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • 10% Owner
    7,665,995 2019-05-13 0

    VIEHBACHER CHRISTOPHER

    • Director
    0 2019-05-08 0

    LEGGETT THOMAS SVP FINANCE, CFO

    • Officer
    0 2019-05-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AXCELLA HEALTH INC AXLA 2022-08-10 21:45:04 UTC -0.2273 2.5473 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 21:15:05 UTC -0.2273 2.5473 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 20:45:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 20:15:06 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 19:45:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 19:15:05 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 18:45:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 18:15:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 17:45:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 17:15:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 16:45:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 16:15:03 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 15:45:05 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 15:15:05 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 14:45:04 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 14:15:03 UTC -0.1766 2.4966 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 13:45:03 UTC -0.1353 2.4553 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 13:15:04 UTC -0.1353 2.4553 150000
    AXCELLA HEALTH INC AXLA 2022-08-10 12:45:05 UTC -0.1353 2.4553 150000
    AXCELLA HEALTH INC AXLA 2022-08-09 22:15:07 UTC -0.1353 2.4553 150000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments